来源：新浪证券-红岸工作室 1月5日，百龙创园涨1.16%，成交额1.44亿元，换手率1.56%，总市值91.77亿元。 异动分析 代糖概念+参股银行+人民币贬值受益+专精特新+海峡两岸 1、公司生产的健康甜味剂产品主要为阿洛酮糖，阿洛酮糖是在自然界中天然存在但含量极少的一种稀 有单糖，其甜味及口感与蔗糖相当类似或接近，但其热量却远低于蔗糖，对于肥胖以及糖尿病患者是一 种理想的蔗糖代替物。 2、2024年半年报，公司持有山东禹城农村商业银行股份有限公司 5.14%股份。 3、根据2024年年报，公司海外营收占比为60.62%，受益于人民币贬值。 (免责声明：分析内容来源于互联网，不构成投资建议，请投资者根据不同行情独立判断) 资金分析 今日主力净流入362.27万，占比0.03%，行业排名33/181，该股当前无连续增减仓现象，主力趋势不明 显；所属行业主力净流入1.84亿，当前无连续增减仓现象，主力趋势不明显。 区间今日近3日近5日近10日近20日主力净流入362.27万-485.05万210.36万-2270.36万-3789.31万 主力持仓 4、专精特新"小巨人"企业是全国中小企业评定工作中最高等级、 ...

1月5日，莱茵生物（维权）盘中上涨2.01%，截至13:06，报8.62元/股，成交7962.63万元，换手率 1.27%，总市值63.93亿元。 资金流向方面，主力资金净流入116.79万元，特大单买入0.00元，占比0.00%，卖出127.77万元，占比 1.60%；大单买入2087.96万元，占比26.22%，卖出1843.41万元，占比23.15%。 莱茵生物今年以来股价涨2.01%，近5个交易日跌8.59%，近20日涨6.95%，近60日涨8.84%。 资料显示，桂林莱茵生物科技股份有限公司位于广西壮族自治区桂林市临桂区人民南路19号，成立日期 2000年11月28日，上市日期2007年9月13日，公司主营业务涉及主要从事天然健康产品的生产经营业 务，持续专注植物功能性成分提取领域。主营业务收入构成为：植物提取产品98.05%，其他业务产品 1.95%。 莱茵生物所属申万行业为：基础化工-化学制品-食品及饲料添加剂。所属概念板块包括：啤酒、专精特 新、融资融券、工业大麻、代糖概念等。 截至9月30日，莱茵生物股东户数4.60万，较上期减少1.66%；人均流通股16011股，较上期增加 31.16%。 ...

以生猪养殖为代表的农牧渔板块今日（12月29日）继续上攻！全市场"含猪量"最高的农牧渔ETF（159275）开盘短暂下探后震荡上行，截至发稿，场内价格 涨0.71%。 成份股方面，生猪养殖、水产饲料等板块部分个股涨幅居前。截至发稿，牧原股份大涨超5%，兄弟科技涨超3%，温氏股份涨超2%，安迪苏、天马科技、生 物股份等多股跟涨超1%。 | | | 分时 多日 1分 5分 15分 30分 = | | | | | F9 盘前盘后 叠加 九转 圆线 工具 砂 | | | 2 > | 农牧渔ETF | | 159275 | | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 0.997 | | | | 159275[农牧渔ETF] 10:32 价 0.996 涨跌 0.007(0.71%) 均价 0.994 成交量 | | | | | 60 0.82% | WP | 0 996 | | +0.007 +0.71% | | | | | | | | | | | | | SZSE CNY 10:32:0 ...

来源：新浪证券-红岸工作室 12月25日，百龙创园涨1.92%，成交额9861.24万元，换手率1.08%，总市值91.60亿元。 异动分析 代糖概念+参股银行+人民币贬值受益+专精特新 1、公司生产的健康甜味剂产品主要为阿洛酮糖，阿洛酮糖是在自然界中天然存在但含量极少的一种稀 有单糖，其甜味及口感与蔗糖相当类似或接近，但其热量却远低于蔗糖，对于肥胖以及糖尿病患者是一 种理想的蔗糖代替物。 2、2024年半年报，公司持有山东禹城农村商业银行股份有限公司 5.14%股份。 3、根据2024年年报，公司海外营收占比为60.62%，受益于人民币贬值。 4、专精特新"小巨人"企业是全国中小企业评定工作中最高等级、最具权威的荣誉称号，是指专注于细 分市场、创新能力强、市场占有率高、掌握关键核心技术、质量效益优的排头兵企业，对于提升中小企 业自身的竞争力，以及提升产业链、供应链稳定性和竞争力具有重大意义。公司已入选工信部专精特新 小巨人企业名单。 (免责声明：分析内容来源于互联网，不构成投资建议，请投资者根据不同行情独立判断) 区间今日近3日近5日近10日近20日主力净流入-240.08万-1154.10万-2480.7 ...

资金流向方面，主力资金净流出4863.30万元，特大单买入1389.02万元，占比5.57%，卖出7028.65万 元，占比28.17%；大单买入5585.97万元，占比22.39%，卖出4809.64万元，占比19.28%。 莱茵生物今年以来股价涨27.10%，近5个交易日涨7.58%，近20日涨12.48%，近60日涨18.16%。 12月25日，莱茵生物（维权）盘中下跌2.09%，截至09:35，报9.37元/股，成交2.49亿元，换手率 3.42%，总市值69.49亿元。 资料显示，桂林莱茵生物科技股份有限公司位于广西壮族自治区桂林市临桂区人民南路19号，成立日期 2000年11月28日，上市日期2007年9月13日，公司主营业务涉及主要从事天然健康产品的生产经营业 务，持续专注植物功能性成分提取领域。主营业务收入构成为：植物提取产品98.05%，其他业务产品 1.95%。 莱茵生物所属申万行业为：基础化工-化学制品-食品及饲料添加剂。所属概念板块包括：专精特新、啤 酒、融资融券、小盘、代糖概念等。 截至9月30日，莱茵生物股东户数4.60万，较上期减少1.66%；人均流通股16011股，较上期增加 ...

12月19日，兄弟科技盘中上涨2.09%，截至13:00，报6.36元/股，成交6065.29万元，换手率1.37%，总市 值72.68亿元。 分红方面，兄弟科技A股上市后累计派现3.90亿元。近三年，累计派现1.06亿元。 资金流向方面，主力资金净流入288.34万元，特大单买入140.52万元，占比2.32%，卖出0.00元，占比 0.00%；大单买入781.91万元，占比12.89%，卖出634.09万元，占比10.45%。 兄弟科技今年以来股价涨49.65%，近5个交易日涨0.00%，近20日跌1.40%，近60日跌10.42%。 今年以来兄弟科技已经9次登上龙虎榜，最近一次登上龙虎榜为9月25日，当日龙虎榜净买入-5801.97万 元；买入总计1.27亿元 ，占总成交额比7.06%；卖出总计1.85亿元 ，占总成交额比10.28%。 资料显示，兄弟科技股份有限公司位于浙江省海宁市海洲街道学林街1号，成立日期2001年3月19日，上 市日期2011年3月10日，公司主营业务涉及维生素、皮革化学品、香精香料、原料药和催化新材料等产 品的研发、生产与销售。主营业务收入构成为：医药食品58.88%，特种化学 ...

Core Viewpoint - The company, Shandong Bailong Chuangyuan Biotechnology Co., Ltd., is experiencing positive market movements, with a recent stock price increase and significant revenue growth, driven by its innovative health sweetener products and strategic investments in the banking sector [1][8]. Group 1: Company Overview - The company specializes in the research, production, and sales of prebiotic series products, dietary fiber series products, and health sweetener products, with a revenue composition of 54.15% from dietary fiber, 28.00% from prebiotics, 13.57% from health sweeteners, and 3.91% from other products [8]. - As of December 10, the company had 12,300 shareholders, an increase of 12.12% from the previous period, with an average of 34,216 circulating shares per shareholder, a decrease of 10.81% [8]. - The company was established on December 30, 2005, and went public on April 21, 2021, located in the Dezhou (Yucheng) National High-tech Industrial Development Zone [8]. Group 2: Financial Performance - For the period from January to September 2025, the company achieved a revenue of 969 million yuan, representing a year-on-year growth of 18.10%, and a net profit attributable to shareholders of 265 million yuan, up 44.93% year-on-year [8]. - The company has distributed a total of 204 million yuan in dividends since its A-share listing, with 193 million yuan distributed over the past three years [9]. Group 3: Market Position and Strategic Advantages - The company produces allulose, a rare monosaccharide that serves as a low-calorie alternative to sucrose, making it ideal for individuals with obesity and diabetes [2]. - The company holds a 5.14% stake in Shandong Yucheng Rural Commercial Bank, benefiting from the depreciation of the RMB [3][4]. - The company has been recognized as a "specialized, refined, characteristic, and innovative" small giant enterprise, which enhances its competitiveness and stability within the industry [4]. Group 4: Stock Market Activity - On December 17, the company's stock rose by 2.68%, with a trading volume of 100 million yuan and a turnover rate of 1.14%, leading to a total market capitalization of 8.862 billion yuan [1]. - The average trading cost of the stock is 20.54 yuan, with the stock price approaching a resistance level of 21.24 yuan, indicating potential for upward movement if this level is surpassed [7].

农牧渔板块今日（12月12日）逆市拉升！全市场唯一农牧渔ETF（159275）开盘后震荡上行，盘中场内 价格最高涨0.83%，截至发稿，涨0.62%。 成份股方面，动保、生猪养殖、水产等板块部分个股涨幅居前。截至发稿，生物股份大涨超4%，罗牛 山、天康生物双双涨超2%，梅花生物、开创国际、中水渔业等多股跟涨超1%。 | 分时 8日 1分 5分 15分 30分 # | F9 盘前盘后 婴加 九转 阅读 工具 (2 > | 农牧渔ETF | 159275 | 159275(农牧渔ETF) 10:29 价 0.974 深跌 0.006(0.62%) 均价 0.972 成交量 25 | 0.074 | +0.006 +0.62% | | | | | | | | | | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 0.976 | 10 + | SZSE CNY 10:29:15 交易中 | | | | ...

Investment Rating - The report maintains a "Recommended" investment rating for the basic chemical industry [2] Core Views - The basic chemical industry is expected to see a layout period at the end of the year, with a high overall weighted operating rate and low price differentials indicating potential for a reversal [14] - The tire industry has shown signs of recovery, with leading companies expected to return to high growth by 2026 due to easing tariffs and recovering raw material costs [15] - The introduction of the "Stabilizing Growth Work Plan for the Petrochemical and Chemical Industry (2025-2026)" is anticipated to accelerate industry transformation and upgrading [16] Summary by Sections Industry Basic Data - The industry comprises 494 listed companies with a total market value of 54,965.58 billion and a circulating market value of 48,900.97 billion [2] Price and Performance - The report indicates a 2.0% absolute performance increase over one month, 28.6% over six months, and 25.6% over twelve months [3] - Key price increases this week include Henry natural gas (+18.5%), ethane (+10.4%), and octanol (+7.8%) [13] Sector Tracking - The tire sector is highlighted for its recovery, with nine out of eleven listed companies reporting profit growth in Q3 [15] - The agricultural chemical sector is noted for recent price increases in small pesticide varieties and the essential nature of fertilizers [7] - The phosphorous chemical sector is under observation for changes in industry dynamics due to favorable policies [7] Investment Strategies - Suggested investment routes include early-stage recovery stocks, scarce resource leaders, high-growth potential companies, and sectors with favorable supply-demand structures [14] - The report emphasizes the importance of focusing on the fluorine, silicon, and phosphorus sectors for their valuation elasticity and potential for new cycle star products [17][18] Policy and Regulatory Developments - The Ministry of Industry and Information Technology has initiated discussions on PTA industry development to prevent excessive competition and promote stable operations [16] - The report notes that the petrochemical sector is expected to undergo significant changes due to new policies aimed at optimizing supply and enhancing technological innovation [19]

Core Viewpoint - The company, Shandong Bailong Chuangyuan Biotechnology Co., Ltd., is experiencing growth in its health sweetener products, particularly allulose, and benefits from its stake in a rural commercial bank, as well as the depreciation of the RMB. Group 1: Company Overview - The company specializes in the research, production, and sales of prebiotics, dietary fibers, and health sweeteners, with a revenue composition of 54.15% from dietary fibers, 28.00% from prebiotics, 13.57% from health sweeteners, and 3.91% from other products [8] - As of November 30, the company had 10,900 shareholders, a decrease of 18.48%, with an average of 38,364 circulating shares per shareholder, an increase of 22.67% [8] - The company was established on December 30, 2005, and went public on April 21, 2021 [8] Group 2: Financial Performance - For the period from January to September 2025, the company achieved a revenue of 969 million yuan, representing a year-on-year growth of 18.10%, and a net profit attributable to shareholders of 265 million yuan, up 44.93% year-on-year [8] - The company has distributed a total of 183 million yuan in dividends since its A-share listing, with 172 million yuan distributed over the past three years [9] Group 3: Market Position and Recognition - The company holds a 5.14% stake in Shandong Yucheng Rural Commercial Bank, which contributes to its financial stability [3] - The company has been recognized as a "specialized, refined, distinctive, and innovative" small giant enterprise, which is a prestigious title in China, indicating its strong market position and innovation capabilities [4] Group 4: Stock Performance and Trading Activity - On December 5, the company's stock rose by 0.24%, with a trading volume of 38.1953 million yuan and a turnover rate of 0.44%, bringing the total market capitalization to 8.631 billion yuan [1] - The average trading cost of the stock is 20.59 yuan, with recent buying activity noted, although the strength of this accumulation is weak [7]